Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 1 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 1 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemorrhage; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 1 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemophilia A; Hemorrhage; Hemostatic Disorders | Phase 3 | ClinicalTrials |
CONTENTS